Kiniksa Pharmaceuticals International PLC Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
423.24M
56.60%
EPS(YoY)
-0.60
-400.82%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its total revenue reached 423.24M, with a year-on-year change of 56.60%.
What is the Earnings Per Share (EPS) of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its Earnings Per Share (EPS) was -0.605, with a year-on-year change of -400.82%.
What is the net income of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its net income was -43.19M, with a year-on-year change of -406.68%.
What is the net margin of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its net profit margin was -10.21%, with a year-on-year change of -295.83%.
What is the gross margin of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its gross margin was 85.61%, with a year-on-year change of -2.32%.
What is the debt-to-asset ratio of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its Return on Equity (ROE) was -9.85%, with a year-on-year change of -391.90%.
What is the Return on Assets (ROA) of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its Return on Assets (ROA) was -7.80%, with a year-on-year change of -373.19%.
What is the operating profit of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its operating profit was -45.62M, with a year-on-year change of -81.04%.
What are the current assets of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its current assets were 331.80M, with a year-on-year change of 20.09%.
What are the total assets of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its total assets of Kiniksa Pharmaceuticals International PLC were 580.55M, with a year-on-year change of 10.30%.
What are the total liabilities of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its total liabilities of Kiniksa Pharmaceuticals International PLC were 142.12M, with a year-on-year change of 62.45%.
What is the total equity of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its total equity of Kiniksa Pharmaceuticals International PLC was 438.44M, with a year-on-year change of -0.09%.
What is the net operating income of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its net operating income of Kiniksa Pharmaceuticals International PLC was -43.19M, with a year-on-year change of -406.68%.
What is the net investment of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its net investment of Kiniksa Pharmaceuticals International PLC was 37.67M, with a year-on-year change of 227.46%.
What is the net financing of Kiniksa Pharmaceuticals International PLC?
According to Kiniksa Pharmaceuticals International PLC's FY2024 earnings report, its net financing of Kiniksa Pharmaceuticals International PLC was 12.27M, with a year-on-year change of 720.47%.